Herein, we demonstrated that MRPL21 regulates PARP1 to inhibit the apoptotic response of HNSCC cells to chemotherapeutic drugs such as cisplatin, and the knockdown of the PARP1 gene can reverse this drug resistance. This evidence concerns the gene MRPL21 and head and neck squamous cell carcinoma.